Search
Categories


Posts Tagged ‘cardiovascular’

Erectile dysfunction is a strong predictor of death in men with cardiovascular disease

Friday, July 9th, 2010

From CNN:Men with cardiovascular disease and ED were twice as likely to die from all causes than men who did not have erectile dysfuncti on. And those with ED were 1.6 times more likely to suffer from a serious cardiovascular problem such as a heart attack or st roke.Erectile dysfunction is something that regularly should be addressed in the medical history of patients; it might be a symptom of early atherosclerosis.Men with ED who are going (more…)

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Sunday, May 30th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated me dical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Health News from Medical News Today)

Phentermine cardiovascular safety In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3.

Thursday, May 27th, 2010

Authors: Rothman RB, Hendricks EJ
A letter to the editor “Cusp tear in bicuspid valve possibly caused by phentermine” published in volume 106 (2006) stated “Phentermine is known to cause valvular disease with prolonged use.” There is no evidence that phentermine causes valvulopathy. Phentermine is the most widely us ed anti-obesity drug. In view of the serious cardiovascular risks associated with obesity, it is important to clarify that phentermine (more…)

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Wednesday, May 26th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News T (more…)

Phentermine cardiovascular safety

Tuesday, May 25th, 2010

A recent case report published in the American Journal of E mergency Medicine described a 48-year-old woman with no significant medical history who developed a myocardial infarction and subsequent ventricular tachycardia/fibrillation. This patient also happened to be taking phentermine, and the aut hors therefore conclude “that this agent, which is a chemical analogue of the potent amphetamine class of noradrenergic stimulants, may have (more…)

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Monday, March 1st, 2010

LEVITRA(R) (vardenafil HCl), is effective at firs t dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News (more…)

Phentermine cardiovascular safety In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3.

Wednesday, February 17th, 2010

Authors: Rothman RB, Hendricks EJ
A letter to the editor “Cusp tear in bicuspid valve possibly caused by phentermine” published in volume 106 (2006) stated “Phentermine is known to cause valvula r disease with prolonged use.” There is no evidence that phentermine causes valvulopathy. Phentermine is the most widely used anti-obesity drug. In view of the serious cardiovascular risks associated with obesity, it is important to clarify that phentermine (more…)

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Tuesday, February 16th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes a nd/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Health News from Medical News Today)

MedWorm Message: (more…)

Phentermine cardiovascular safety

Wednesday, February 10th, 2010

A recent case report published in the American Journal of Emer gency Medicine described a 48-year-old woman with no significant medical history who developed a myocardial infarction and subsequent ventricular tachycardia/fibrillation. This patient also happened to be taking phentermine, and the authors therefore conclude “that this agent, which is a chemical analogue of the potent amphetamine cla ss of noradrenergic stimulants, may have the (more…)